Effects of cytosine arabinoside on human leukemia cells

The International Journal of Biochemistry & Cell Biology - Tập 28 Số 9 - Trang 1061-1069 - 1996
Leesa B. Crisp1, Suzanne M. Smith2, Margaret A.G. Mathers2, Graham Young3, Stephen D. Lyons2, Richard I. Christopherson2
1Department of Biochemistry, University of Sydney, NSW, Australia.
2Department of Biochemistry, University of Sydney, Sydney, NSW 2006 Australia
3Kanematsu Laboratories, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bebenek, 1992, The effects of dNTP pool imbalances on frameshift fidelity during DNA replication, J. biol. Chem., 267, 3589, 10.1016/S0021-9258(19)50565-8

Brooke, 1990, Cytotoxic effects of dihydroorotase inhibitors upon human CCRF-CEM leukemia, Cancer Res., 50, 7793

Eriksson, 1979, Allosteric regulation of calf thymus ribonucleoside diphosphate reductase, Biochemistry, 18, 2948, 10.1021/bi00581a005

Kucera, 1992, 1-β-D-Arabinofuranosylcytosine-disphosphate-choline is formed by the reversal of choline phosphotransferase and not via cytidyltransferase, Cancer Res., 52, 3886

Kufe, 1980, Correlation of cytotoxicity with incorporation of Ara-C into DNA, J. biol. Chem., 255, 8997, 10.1016/S0021-9258(19)70512-2

Kufe, 1984, Effects of 1-β-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function, Mol. Pharmacol., 26, 128

Lyons, 1990, Effects of brequinar and ciprofloxacin on de novo nucleotide biosynthesis in mouse L1210 leukemia, Biochem. Int., 22, 939

Muus, 1991, 1-β-D-Arabinofuranosylcytosine (Ara-C) enhances mitochondrial activities in human leukemic cells, Br. J. Cancer, 64, 29, 10.1038/bjc.1991.234

Owens, 1992, Resistance to 1-β-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene, Cancer Res., 52, 2389

Pallavicini, 1984, Cytosine arabinoside: molecular, pharmacokinetic and cytokinetic considerations, Pharmac. Ther., 25, 207, 10.1016/0163-7258(84)90044-5

Peters, 1988, High-dose cytosine arabinoside: pharmacological and clinical aspects, Blut, 56, 1, 10.1007/BF00321053

Ross, 1986, Metabolism of Ara-C from blast cells from patients with ANLL, Blood, 68, 76, 10.1182/blood.V68.1.76.76

Sant, 1992, Antifolates induce inhibition of amido phosphoribosyltransferase in leukemia cells, J. biol. Chem., 267, 11038, 10.1016/S0021-9258(19)49872-4

Tattersall, 1974, Mechanisms of resistance of human acute leukemia cells to cytosine arabinoside, Br. J. Haematol., 27, 39, 10.1111/j.1365-2141.1974.tb06772.x

Wang, 1990, The effect of Ara-C-induced inhibition of DNA synthesis on its cellular pharmacology, Cancer Chemother. Pharmacol., 25, 418, 10.1007/BF00686052

White, 1991, A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-β-Darabinofuranosylcytosine phosphorylation in human leukemia cells, Cancer Res., 51, 2559

Wiley, 1985, Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma, J. Clin. Invest., 75, 632, 10.1172/JCI111741

Woodcock, 1987, Cytosine arabinoside toxicity: molecular events, biological consequences, and their implications, Sem. Oncol., 14, 251